Industry: Siemens Healthineers - Artificial Intelligence in the prostate cancer pathway

Industry: Siemens Healthineers - Artificial Intelligence in the prostate cancer pathway

Industry
AIClinical oncologyIndustryOncologistsOncologyProstateRadiographyRadiologyRadiologistsRadiotherapistsRadiotherapyUrology

Information

Speakers: Hasan Jouni, Business Development Manager – Digital Health and Sabine Bernard, Senior Product Marketing Manager, Siemens Healthineers 

With the acquisition of Varian Medical Systems, Siemens Healthineers is creating a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global fight against cancer. Hear how as a combined company our AI portfolio can support you and your patients through the prostate cancer pathway.  

Siemens HealthineersSiemens Healthineers is shaping the future of Healthcare. As a leading medical technology company Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit www.siemens-healthineers.co.uk .

Registered attendees

John Burton
John Burton
Principal RadiographerEdinburgh Cancer Centre

Log in